Compare ResMed Inc. (RMD) vs United Airlines Holdings Inc (UAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs United Airlines Holdings Inc — how do they compare? ResMed Inc. trades at $219.5 (market cap $31.89B), while United Airlines Holdings Inc trades at $107.35 (market cap $35.13B). The key difference: ResMed Inc. and United Airlines Holdings Inc are close in size by market cap, and ResMed Inc. pays a 1.19% dividend while United Airlines Holdings Inc pays none. Which is the better fit depends on your goals.
| RMD | UAL | |
|---|---|---|
Market Cap | $31.89B | $35.13B |
Sector | Health | Industrials |
52-Week High | $283.28 | $136.11 |
52-Week Low | $182.82 | $85.21 |
Enterprise Value | $31.24B | $52.16B |
Dividend Yield | 1.19% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ResMed (RMD) trades at $221.05, down 3.2% amid a bearish technical signal, though it holds above key support at $218. The company reported strong Q4 2026 results with EPS of $2.95 beating estimates, and revenue grew 9% to a record $1.5 billion. However, weaker fiscal 2027 revenue guidance has pressured the stock. Fundamentals remain solid with a 26.94% net income margin and robust cash flow from operations of $1.75 billion in 2025.
The outlook is mixed; strong profitability and consistent earnings beats support upside toward the $235.70 consensus price target, but near-term sentiment is cautious due to the soft sales forecast and ongoing legal investigations. Key risks include competitive pressures and execution on guidance. Institutional buying by firms like HSBC and Canada Pension Plan provides confidence in long-term value.
United Airlines (UAL) trades at $108.24, down 2.82% today, with a bearish technical signal but strong fundamentals including a P/E of 10.13 and net income margin of 5.56%. Recent earnings beats and a major international expansion announced in August 2026 highlight growth potential, though cash flow turned negative in 2025 due to capital investments.
The outlook is positive with a consensus price target of $168.96 (56% upside), supported by 66% analyst buy ratings. Risks include high jet fuel costs and geopolitical tensions, but robust travel demand and efficient operations position UAL for recovery if macroeconomic pressures ease.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About United Airlines Holdings Inc
United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →
